Clinical Trial

Study to Assess Efficacy and Safety of HSK39297 Tablets in Patients With LN

Name: Study to Assess Efficacy and Safety of HSK39297 Tablets in Patients With LN — clinical trial record (NCT07363460)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

A double-blind,placebo controlled,randomized Phase 2 study to evaluate the safety and tolerability of once-daily, oral administration of 200 or 300 mg HSK39297 tablets versus placebo in Patients With Lupus Nephritis

Trial Details

NCT Number	NCT07363460
Lead Sponsor	Haisco Pharmaceutical Group Co., Ltd.
Conditions	Lupus Nephritis (LN)
Enrollment	105 participants
Start Date	2025-11-18
Primary Completion	2027-11-05 (estimated)
Study Completion	2028-07-06 (estimated)
Updated on ClinicalTrials.gov	2026-01-23